Azole drug resistance in Candida species

References

1. Kerridge D. Mode of action of clinically important antifungal drugs. Adv Microb Physiol 1986; 27:1–72
   [Google Scholar]
2. Kerridge D., Nicholas R. O. Drug resistance in the opportune istic pathogens Candida albicans and Candida glabrata . J Antimicrob Chemother 1986; 18: Suppl B 39–49
   [Google Scholar]
3. Horsburgh C. R., Kirkpatrick C. H. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am J Med 1983; 74: Suppl 1B23–29
   [Google Scholar]
4. Warnock D. W., Johnson E. M., Richardson M. D., Vickers C. F. H. Modified response to ketoconazole of Candida albicans from a treatment failure. Lancet 1983; 1:642–643
   [Google Scholar]
5. Smith K. J., Warnock D. W., Kennedy C. T. C. Azole resistance in Candida albicans . J Med Vet Mycol 1986; 24:133–144
   [Google Scholar]
6. Johnson E. M., Richardson M. D., Warnock D. W. In-vitro resistance to imidazole antifungals in Candida albicans . J Antimicrob Chemother 1984; 13:547–558
   [Google Scholar]
7. Odds F. C., Abbott A. B. Relative inhibition factors—a novel approach to the assessment of antifungal antibiotics in vitro. J Antimicrob Chemother 1984; 13:31–43
   [Google Scholar]
8. Ryley J. F., Wilson R. G., Barrett-Bee K. J. Azole resistance in Candida albicans . J Med Vet Mycol 1984; 22:53–63
   [Google Scholar]
9. Hitchcock C. A., Barrett-Bee K. J., Russell N. J. Inhibition of 14 α-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole. J Med Vet Mycol 1987; 25:329–333
   [Google Scholar]
10. Tavitian A., Raufman J. P., Rosenthal L. E., Weber J., Webber C. A., Dincsoy H. P. Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome. Gastroenterology 1986; 90:443–445
    [Google Scholar]
11. De Wit S., Weerts D., Goossens H., Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989; 1:746–748
    [Google Scholar]
12. Fox R., Neal K. R., Leen C. L. S., Ellis M. E., Mandal B. K. Fluconazole resistant Candida in AIDS. J Infect 1991; 22:201–204
    [Google Scholar]
13. Kitchen V. S., Savage M., Harris J. R. W. Candida albicans resistance in AIDS. J Infect 1991; 22:204–205
    [Google Scholar]
14. Smith D., Boag F., Midgley J., Gazzard B. Fluconazole resistant Candida in AIDS. J Infect 1991; 23:345–346
    [Google Scholar]
15. Willocks L., Leen C. L. S., Brettle R. P., Urquhart D., Russell T. B., Milne L. J. R. Fluconazole resistance in AIDS patients. J Antimicrob Chemother 1991; 28:937–939
    [Google Scholar]
16. Dupont B. Antifungal therapy in AIDS patients. In Bennett J. E., Hay R. J., Peterson P. K. (eds) New strategies in fungal disease Edinburgh: Churchill Livingstone; 1992290–300
    [Google Scholar]
17. Odds F. C. Laboratory tests for the activity of imidazole and triazole antifungal agents in vitro . Semin Dermatol 1985; 4:260–270
    [Google Scholar]
18. Warnock D. W., Burke J., Cope N. J., Johnson E. M., Von Fraunhofer N. A., Williams E. W. Fluconazole resistance in Candida glabrata . Lancet 1988; 2:1310
    [Google Scholar]
19. Case C. P., Macgowan A. P., Brown N. M., Reeves D. S., Whitehead P., Felmingham D. Prophylactic oral fluconazole and Candida fungaemia. Lancet 1991; 337:790
    [Google Scholar]
20. Mcllroy M. A. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis. J Infect Dis 1991; 163:420–421
    [Google Scholar]
21. Persons D. A., Laughlin M., Tanner D., Perfect J., Gockerman J. P., Hathorn J. W. Fluconazole and Candida krusei fungemia. N Engl J Med 1991; 325:1315
    [Google Scholar]
22. Wingard J. R., Merz W. G., Rinaldi M. G., Johnson T. R., Karp J. E., Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325:1274–1277
    [Google Scholar]